SynthesisBriefings in bioinformatics2025
Computational immunology in venom research: a systematic review of epitope prediction and validation approaches.
Synthesis in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Venom-based therapies are hindered by traditional discovery methods that are costly and inconsistent. Immunoinformatics offers a faster route to identify immunogenic epitopes, yet its application to venom proteins remains limited. We conducted a systematic review under PRISMA-2020 guidelines to identify studies predicting venom toxin epitopes computationally and validating them experimentally. Risk of bias was evaluated using a custom 20-question checklist. Following our systematic search, 11 articles met inclusion criteria. Multitool prediction strategies consistently outperformed single-tool approaches, particularly when structural and sequence-based models were combined. Experimental validations confirmed immunogenicity through diverse assays, but reporting inconsistencies, limited negative data, and variable study designs impaired direct comparison. Toxin family and structural data availability emerged as key factors influencing prediction success. In silico epitope prediction, combined with experimental validation, holds strong promise for advancing venom research. Our systematic bias assessment underscores the critical need for standardized frameworks to evaluate dataset selection, algorithm parameters, and validation rigor in computational epitope discovery. Moreover, the field must urgently address data scarcity, standardize validation protocols, and expand venom-specific training datasets to fully realize the promise of immunoinformatics-driven discovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.